Antihyperglycemic mechanism of M16209, an antidiabetic agent, in 3T3-L1 adipocytes
- 11 April 1997
- journal article
- Published by Elsevier in Life Sciences
- Vol. 60 (20) , 1821-1831
- https://doi.org/10.1016/s0024-3205(97)00142-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effects of M16209, a new antihyperglycemic agent, on insulin sensitivity in vivo: Euglycemic clamp studies in ratsMetabolism, 1996
- Amelioration of insulin resistance in genetically obese rodents by M16209, a new antidiabetic agentEuropean Journal of Pharmacology, 1996
- Effects of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic ratsEuropean Journal of Pharmacology, 1995
- Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic ratsEuropean Journal of Pharmacology, 1995
- The insulin signaling system.Journal of Biological Chemistry, 1994
- Regulation of glucose transporter synthesis in cultured human skin fibroblastsMolecular and Cellular Endocrinology, 1991
- Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in ratsEuropean Journal of Pharmacology, 1991
- Properties of Novel Aldose Reductase Inhibitors, M16209 and M16287, in Comparison with Known Inhibitors, ONO-2235 and Sorbinil.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Effects of Novel Hydantoin Derivatives with Aldose Reductase Inhibiting Activity on Galactose-Induced Cataract in RatsThe Japanese Journal of Pharmacology, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976